GSE195568 palbociclib 6 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE195568_palbociclib_6_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE195568_palbociclib_6_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE195568_palbociclib_6_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE195568_palbociclib_6_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 205

Gene

MT-CO2 pseudogene 12

Gene

DPPA2 upstream binding RNA

Gene

long intergenic non-protein coding RNA 1963

Gene

MT-ATP6 pseudogene 1

Gene

PSMG3 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1128

Gene

long intergenic non-protein coding RNA 2035

Gene

UBA6 divergent transcript

Gene

ribosomal protein L23a pseudogene 82

  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    MT-CO2 pseudogene 12


  • Gene

    DPPA2 upstream binding RNA


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    PSMG3 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1128


  • Gene

    long intergenic non-protein coding RNA 2035


  • Gene

    UBA6 divergent transcript


  • Gene

    ribosomal protein L23a pseudogene 82

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.